12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder

Stein, Dan J. ; Khoo, Jon-Paul ; Ahokas, Antti ; Jarema, Marek ; Van Ameringen, Michael ; Vavrusova, Livia ; Hӧschl, Cyril ; Bauer, Michael ; Bitter, Istvan ; Mosolov, Sergey N. ; Olivier, Valérie ; Matharan, Sophie ; Picarel-Blanchot, Françoise ; de Bodinat, Christian

European neuropsychopharmacology, 2018-08, Vol.28 (8), p.970-979 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível